<DOC>
	<DOCNO>NCT02177305</DOCNO>
	<brief_summary>Safety tolerability ocular administration</brief_summary>
	<brief_title>Dose Tolerance Study After Ocular Administration Tiotropium Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Healthy male Age range 21 50 year Within ± 20 % normal weight ( BrocaIndex ) Written informed consent give Results medical examination laboratory test judge clinical investigator differ significantly normal clinical value Volunteers know gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Volunteers disease central nervous system ( epilepsy ) psychiatric disorder Volunteers know history orthostatic hypotension , faint spell blackouts Volunteers chronic relevant acute infection Volunteers history allergy/ hypersensitivity ( include drug allergy ) Volunteers know eye disease ( incl . glaucoma ) , hyperopia ( &gt; 3 diopter ) contact lenses Volunteers intraocular pressure &gt; 22 mmHg Volunteers predisposition narrowangle glaucoma Volunteers disturb micturition Volunteers take drug long halflife ( ≥ 24 hour ) within ten halflives respective drug enrolment study Volunteers receive drug might influence result trial week previous start study Volunteers participate another study investigational drug within last two month precede study Volunteers smoke ( &gt; 10 cigarette 3 cigar 3 pipes/day ) Volunteers able refrain smoking study day Volunteers drink 40 g alcohol per day Volunteers dependent drug Volunteers donate blood ( ≥ 100 ml ) within last four week Volunteers participate excessive physical activity ( e.g . competitive sport ) within last week study</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>